PharmaCyte Biotech, Inc. (PMCB) SEC filings
PMCB SEC filings moved a median of -0.74% by the close. PMCB SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PMCB overview →
45 measured PMCB SEC filing events.
Where these PMCB SEC filings landedvs 44 measured PMCB SEC filing reactions
| Middle 50% of PMCB SEC filing reactions | -2.07% to +2.64% |
|---|---|
| Median reaction (to close) | -0.74% |
| Measured reactions | 44 |
Point-in-time · zero look-ahead
Half of the 44 PMCB SEC filing events with a measured close landed between -2.07% and +2.64%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K PharmaCyte Biotech, Inc. For: Oct 14 | SEC filing · Form 8-K | — | — | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | +0.95% | -2.61% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | -1.45% | -0.88% | |
| Form 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form 10-K | +0.00% | +2.48% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Mar 30 | SEC filing · Form 8-K | -0.95% | +1.51% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jan 31 | SEC filing · Form 10-Q | -0.78% | -0.82% | |
| Form ARS PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form ARS | +9.45% | -2.39% | |
| Form DEF 14A PharmaCyte Biotech, Inc. For: Mar 30 | SEC filing · Form DEF | -7.39% | -9.61% | |
| Form PRE 14A PharmaCyte Biotech, Inc. For: Mar 30 | SEC filing · Form PRE | -0.85% | +3.42% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form 10-Q | +2.42% | +2.88% | |
| Form NT 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form NT | +1.98% | +4.40% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Dec 01 | SEC filing · Form 8-K | -0.02% | -1.71% | |
| Form 8-K/A PharmaCyte Biotech, Inc. For: Sep 02 | SEC filing · Form 8-K | -0.85% | -5.62% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Oct 30 | SEC filing · Form 8-K | +0.00% | -1.35% | |
| Form DEF 14A PharmaCyte Biotech, Inc. For: Oct 30 | SEC filing · Form DEF | +0.00% | -0.98% | |
| Form EFFECT PharmaCyte Biotech, Inc. | SEC filing · Form EFFECT | -2.79% | -2.97% | |
| Form PRE 14A PharmaCyte Biotech, Inc. For: Oct 30 | SEC filing · Form PRE | -3.74% | -9.25% | |
| Form S-3 PharmaCyte Biotech, Inc. | SEC filing · Form S-3 | +0.04% | -4.82% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | +0.00% | -6.48% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Sep 02 | SEC filing · Form 8-K | +0.00% | +16.50% | |
| Form D PharmaCyte Biotech, Inc. | SEC filing · Form D | +0.00% | -0.66% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Aug 17 | SEC filing · Form 8-K | +4.84% | +13.85% | |
| Form 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form 10-K | -1.17% | +5.53% | |
| Form NT 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form NT | +0.00% | +0.49% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Apr 24 | SEC filing · Form 8-K | +0.00% | +4.27% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jan 31 | SEC filing · Form 10-Q | -0.63% | -5.06% | |
| Form ARS PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form ARS | — | -1.68% | |
| Form DEF 14A PharmaCyte Biotech, Inc. For: Apr 24 | SEC filing · Form DEF | — | -1.68% | |
| Form DEFA14A PharmaCyte Biotech, Inc. | SEC filing · Form DEFA14A | — | -1.68% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Feb 21 | SEC filing · Form 8-K | — | -0.58% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form 10-Q | +0.00% | -1.74% | |
| Form S-8 PharmaCyte Biotech, Inc. | SEC filing · Form S-8 | +0.00% | +0.00% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form 10-Q | +0.00% | +5.03% | |
| Form NT 10-Q PharmaCyte Biotech, Inc. For: Jul 31 | SEC filing · Form NT | +0.00% | +5.03% | |
| Form 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form 10-K | +0.00% | +3.28% | |
| Form NT 10-K PharmaCyte Biotech, Inc. For: Apr 30 | SEC filing · Form NT | +0.06% | +2.56% | |
| Form 8-K PharmaCyte Biotech, Inc. For: May 20 | SEC filing · Form 8-K | — | -0.47% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Apr 29 | SEC filing · Form 8-K | — | +0.47% | |
| Form ARS PharmaCyte Biotech, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | -2.07% | |
| Form DEF 14A PharmaCyte Biotech, Inc. For: Apr 29 | SEC filing · Form DEF | +0.00% | -2.07% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Jan 31 | SEC filing · Form 10-Q | -2.44% | +6.47% | |
| Form 10-Q PharmaCyte Biotech, Inc. For: Oct 31 | SEC filing · Form 10-Q | +0.00% | -3.56% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Nov 20 | SEC filing · Form 8-K | -2.62% | -0.86% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Nov 14 | SEC filing · Form 8-K | +0.00% | +0.50% | |
| Form 8-K PharmaCyte Biotech, Inc. For: Nov 05 | SEC filing · Form 8-K | — | +1.88% |
Keep exploring
More PMCB: earnings → · analyst actions → · PMCB overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
| Molecular Templates, Inc. (MTEM) | 84 | -0.48% | 39% |
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.